What is the Current Share Price of Piramal Pharma Ltd?
- Answer Field
-
Piramal Pharma Ltd share price is for NSE ₹ 168.58 & for BSE ₹ 168.65 as on Jul 01 2026 10:19 AM.
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
PIRAMAL PHARMA LIMITED is currently trading at ₹168.58, up by ₹0.49 from the previous close. The stock touched an intraday high of ₹173.10 and a low of ₹168.01 during the latest trading session. Over the past one year, PIRAMAL PHARMA LIMITED has delivered a loss of 18.02%, while the stock has declined 3.51% in the last one month.
| Particulars | MAR 2026 (Values in Cr) |
|---|---|
| Revenue | 1489.06 |
| Operating Expense | 1275.33 |
| Net Profit | 261.63 |
| Net Profit Margin (%) | 17.57 |
| Earnings Per Share (EPS) | 1.97 |
| EBITDA | 421.47 |
| Effective Tax Rate (%) | 21.16 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 31.08 | 12.84 | 1.50 | 238.18 | 23.12 | 38.85 |
| BLISS GVS PHARMA LTD | 530.35 | 43.05 | 4.71 | 5624.69 | 118.35 | 541.75 |
| CIPLA LTD | 1453.50 | 30.85 | 3.41 | 117420.32 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 356.70 | 15.73 | 2.58 | 1049.80 | 256.40 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 31.08 | 21.73 | 4.00 | 238.18 | 23.12 | 38.85 |
| AMRUTAJAN HEALTH LTD | 539.05 | 24.16 | 4.20 | 1558.43 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA IND LT | 8054.15 | 105.19 | 23.07 | 20135.38 | 7630.00 | 9850.00 |
| BLISS GVS PHARMA LTD | 530.35 | 57.21 | 4.86 | 5624.69 | 118.35 | 541.75 |
| Particulars | Sep 2024 (₹ Cr) | Jun 2024 (₹ Cr) | Mar 2024 (₹ Cr) | Dec 2023 (₹ Cr) | Sep 2023 (₹ Cr) |
|---|---|---|---|---|---|
| Revenue | 1284.39 | 1063.20 | 1525.30 | 1024.14 | 994.24 |
| Operating Expense | 1115.06 | 988.30 | 1215.82 | 967.58 | 987.13 |
| Net Profit | 210.06 | 85.27 | 273.08 | 74.34 | 77.16 |
| Net Profit Margin (%) | 16.35 | 8.02 | 17.90 | 7.25 | 7.76 |
| Earnings Per Share (EPS) | 1.59 | 0.64 | 2.06 | 0.56 | 0.61 |
| EBITDA | 359.27 | 188.39 | 442.83 | 158.64 | 175.24 |
| Effective Tax Rate (%) | 23.81 | 23.63 | 24.70 | 17.08 | 19.78 |
Key Highlights
| Particulars | Value (₹ Cr) |
|---|---|
| Revenue | 4390.11 |
| Operating Expense | 4084.54 |
| Net Profit | 391.22 |
| Net Profit Margin (%) | 8.91 |
| Earnings Per Share (EPS) | 3.05 |
| EBITDA | 819.98 |
| Effective Tax Rate (%) | 22.93 |
Key Highlights
| Particulars | Value |
|---|---|
| Dividend Yield | 0.04% |
| Earnings Per Share (EPS) | ₹3.05 |
| Net Profit | ₹391.22 Cr |
| Piramal Pharma Share Price | ₹273.45 |
Key Highlights
1. Who is the CEO of Piramal Pharma Ltd?
The CEO of Piramal Pharma Ltd is Nandini Piramal. She is also the Chairperson of Piramal Enterprises Ltd, which is the parent company of Piramal Pharma Ltd. Under her leadership, the company has expanded its offerings in the pharmaceutical sector, including drug discovery, development, and manufacturing services.
2. When was Piramal Pharma Ltd established?
Piramal Pharma Ltd was incorporated on March 4, 2020, as a public limited company. The company was subsequently registered with the Registrar of Companies (RoC). It came into existence as a part of Piramal Enterprises Ltd's strategic reorganisation, which aimed to demerge its pharmaceutical business and expand its capabilities in drug manufacturing, biologics, vaccines, and self-care products.
3. What factors influence the Piramal Pharma Share Price?
The Piramal Pharma share price is influenced by various factors, including the company’s financial performance, industry growth, and global demand for pharmaceutical products. Key drivers include the company’s expansion into biologics and vaccines, joint ventures with companies like Allergan (now AbbVie), and the launch of new products. Other factors such as regulatory changes, competition in the pharmaceutical industry, and global market conditions also impact the Piramal Pharma share price.
4. Is Piramal Pharma Ltd debt-free?
No, Piramal Pharma Ltd is not debt-free. The company has undertaken strategic acquisitions and investments, which sometimes involve debt financing. However, Piramal Pharma has a strong portfolio of differentiated products and services, a global manufacturing footprint, and an expanding distribution network that support its ability to manage and service its debt.
5. What is the CAGR of Piramal Pharma Share?
The Compound Annual Growth Rate (CAGR) of the Piramal Pharma share price is not readily available for 10 years and 5 years. However, the share price has performed well over the past year, with a notable increase of 117%. This growth is indicative of the company’s positive trajectory, particularly following the demerger from Piramal Enterprises Ltd and its strategic investments and acquisitions.
6. How has the Piramal Pharma Share Price performed over the past year?
The Piramal Pharma share price has performed exceptionally well over the past year, with a significant increase of 117%. This growth can be attributed to the company's strategic initiatives, including the expansion of its product offerings, the successful demerger from Piramal Enterprises, and its continued expansion into high-demand sectors such as biologics and vaccines. The company has also strengthened its global presence, which has positively impacted investor confidence and share price performance.
Sign-in to trade with your demat account, or set up a new demat account for free
Piramal Pharma Ltd share price is for NSE ₹ 168.58 & for BSE ₹ 168.65 as on Jul 01 2026 10:19 AM.
The market cap of Piramal Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 01 2026 10:19 AM.
The 52 Week High and Low of Piramal Pharma Ltd for NSE is ₹ 220.85 and ₹ 132.30 and for BSE is ₹ 220.90 and ₹ 132.50.
The 1 year returns on the stock has been -18.02%.
As on Jul 01 2026 10:19 AM the price-to-earnings (PE) ratio for Piramal Pharma Ltd share is 31.68.
As on Jul 01 2026 10:19 AM, the price-to-book (PB) ratio for Piramal Pharma Ltd share is 61.18.
You can trade in Piramal Pharma Ltd shares with Bajaj Broking by opening a demat account.
To buy Piramal Pharma Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Piramal Pharma Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found